The short version of N-terminal modification fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-28. Anything still debated is marked as such rather than presented as settled.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
=== August === 1 August – A study in Nature finds that based on current policies, there is a 45% risk of at least one major tipping point by 2300, even if global warming is brought back to below 1.5 °C. The risk is "strongly accelerated" for peak warming above 2.0 °C. The Atlantic Meridional Overturning Current (AMOC) is identified as being at the most urgent risk of collapse – possibly occurring as early as 2040 – followed by the Amazon rainforest in the 2070s. 5 August A study indicates vegetarian and vegan dog diets are healthier than both conventional meat and raw meat diets according to indicators like numbers of veterinary visits and reported veterinary assessment of being unwell, consistent with all related studies published to date. An analysis suggests hydraulic lifts may have been used to build ancient large Egyptian pyramids. 7 August – Scientists in Australia publish a new 400-year temperature reconstruction for the Coral Sea, showing that recent ocean heat has led to mass bleaching on the Great Barrier Reef. 8 August – A study on the terraforming of Mars suggests that releasing metal nanorods into the planet's atmosphere could warm it by 30 K, and would be far more efficient than trying to do so with greenhouse gases. 12 August Liquid water is confirmed to be present at depths of 10 to 20 km (6.2 to 12.4 mi) below the surface of Mars, based on a new analysis of data from NASA's InSight lander. An Earth-sized, ultra-short period exoplanet called TOI-6255b is found to be undergoing extreme tidal distortion, caused by the close proximity of its parent star.
== Contamination incidents == The company has been involved in several controversial incidents of proven and alleged corporate crimes, including exposing workers and residents of an entire town to asbestos contamination in Libby and Troy, Montana, water contamination (the basis of the book and film A Civil Action) in Woburn, Massachusetts, and an Acton, Massachusetts, Superfund site.
The ONS publishes its latest forecast of UK population, suggesting that the number of people in the UK could rise from 67 to 73.7 million by 2036, driven by strong immigration. 31 January Post-Brexit controls on food, plant and animal imports to Britain from the EU come into force. 2024 Northern Ireland Executive Formation: Details of a deal between the UK government and the Democratic Unionist Party (DUP) to restore devolution in Northern Ireland are published. Nine people, including three police officers, are taken to hospital following an attack using what is described as a "corrosive substance" on a car in Clapham, south west London. The suspect is named as Abdul Shakoor Ezedi, a 35-year-old man from the "Newcastle area".
Sources: en.wikipedia.org
Radiopharmacology is radiochemistry applied to medicine and thus the pharmacology of radiopharmaceuticals (medicinal radiocompounds, that is, pharmaceutical drugs that are radioactive). Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. In the book Technetium a total of 31 different radiopharmaceuticals based on Tc-99m are listed for imaging and functional studies of the brain, myocardium, thyroid, lungs, liver, gallbladder, kidneys, skeleton, blood and tumors. The term radioisotope, which in its general sense refers to any radioactive isotope (radionuclide), has historically been used to refer to all radiopharmaceuticals, and this usage remains common. Technically, however, many radiopharmaceuticals incorporate a radioactive tracer atom into a larger pharmaceutically-active molecule, which is localized in the body, after which the radionuclide tracer atom allows it to be easily detected with a gamma camera or similar gamma imaging device. An example is fludeoxyglucose in which fluorine-18 is incorporated into deoxyglucose. Some radioisotopes (for example gallium-67, gallium-68, and radioiodine) are used directly as soluble ionic salts, without further modification. This use relies on the chemical and biological properties of the radioisotope itself, to localize it within the body.
==== Basic metabolic panel ==== BMP is a panel of tests that measures eight analytes in the blood's fluid portion (plasma). The results of the BMP provide valuable information about a patient's kidney function, blood sugar level, electrolyte levels, and the acid-base balance. Abnormal changes in one or more of these analytes can be a sign of serious health issues:
=== Other uses === CPA is useful in the treatment of hot flashes, for instance due to androgen deprivation therapy for prostate cancer. CPA is useful for suppressing the testosterone flare at the initiation of GnRH agonist therapy. It has been used successfully both alone and in combination with estrogens such as diethylstilbestrol for this purpose.
Sources: en.wikipedia.org
== Uses == Madecassic acid is used in both traditional and modern medicine, particularly in dermatology and wound care. As a triterpene, madecassic acid also exhibits notable antioxidant benefits, assisting in protecting skin from the pro-aging damage that environmental aggressors, like UV rays and pollution, can cause.
The restaurant serves fried chicken, catfish, chicken tenders, and side dishes. The chain is also known for their iced tea, which they sell by the gallon. Chicken Express is headquartered in Burleson, Texas and has over 200 locations in Texas, Arkansas, Louisiana and Oklahoma.
Marine carbon is further separated into particulate and dissolved phases. These pools are operationally defined by physical separation – dissolved carbon passes through a 0.2 μm filter, and particulate carbon does not. There are two main types of inorganic carbon that are found in the oceans:
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.